Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Recruiting 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 37Carcinoma, Hepatocellular 14Ovarian Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 3Rectal Neoplasms 3Neoplasm Metastasis 3Glioblastoma 3Recurrence 2Liver Neoplasms 2Diabetes Mellitus, Insulin-Dependent, 12 2Brain Neoplasms 2mCRC 1Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Spinocerebellar Degenerations 1Small Cell Lung Carcinoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms Malignant 1Proteinuria 1Platinum-sensitive Relapsed Ovarian Cancer 1Platinum-resistant Recurrent Ovarian Cancer (PROC) 1Platinum-resistant Recurrent Ovarian Cancer 1Osteosarcoma 1Non-small Cell Lung Cancer Patients with Brain Metastases 1Neutropenia 1Neoplastic Cells, Circulating 1NSCLC 1Metastatic Colorectal Cancer With Left-sided Primary Tumor 1Medulloblastoma 1

Interventions

Etoposide 15Carboplatin 14Cisplatin 9anlotinib 8PM 01183 6toripalimab 5Drug Therapy 5tislelizumab 4atezolizumab 4Topotecan 4Radiotherapy 4Platinum 4irinotecan sucrosofate 3durvalumab 3famitinib 2apatinib 2Pemetrexed 2Paclitaxel 2EC regimen 2sintilimab 1osimertinib 1nintedanib 1fludarabine 1amrubicin 1Tomography, X-Ray Computed 1Tissue Banks 1Radiation Dose Hypofractionation 1Rabeprazole 1Proton Pump Inhibitors 1Platinum Compounds 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Small Cell Lung Carcinoma × Bevacizumab × Clear all
NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Shanghai JMT-Bio Inc.

Phase 1/2 Not yet recruiting
596 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡